FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3172854200> ?p ?o ?g. }

• W3172854200 endingPage "9216" @default.
• W3172854200 startingPage "9193" @default.
• W3172854200 abstract "Failure to resolve inflammation underlies many prevalent pathologies. Recent insights have identified lipid mediators, typified by lipoxins (LXs), as drivers of inflammation resolution, suggesting potential therapeutic benefit. We report the asymmetric preparation of novel quinoxaline-containing synthetic-LXA4-mimetics (QNX-sLXms). Eight novel compounds were screened for their impact on inflammatory responses. Structure-activity relationship (SAR) studies showed that (R)-6 (also referred to as AT-02-CT) was the most efficacious and potent anti-inflammatory compound of those tested. (R)-6 significantly attenuated lipopolysaccharide (LPS)- and tumor-necrosis-factor-α (TNF-α)-induced NF-κB activity in monocytes and vascular smooth muscle cells. The molecular target of (R)-6 was investigated. (R)-6 activated the endogenous LX receptor formyl peptide receptor 2 (ALX/FPR2). The anti-inflammatory properties of (R)-6 were further investigated in vivo in murine models of acute inflammation. Consistent with in vitro observations, (R)-6 attenuated inflammatory responses. These results support the therapeutic potential of the lead QNX-sLXm (R)-6 in the context of novel inflammatory regulators." @default.
• W3172854200 created "2021-06-22" @default.
• W3172854200 creator A5000110120 @default.
• W3172854200 creator A5001231574 @default.
• W3172854200 creator A5002300160 @default.
• W3172854200 creator A5009364870 @default.
• W3172854200 creator A5016097947 @default.
• W3172854200 creator A5021761166 @default.
• W3172854200 creator A5024695885 @default.
• W3172854200 creator A5032456908 @default.
• W3172854200 creator A5032771884 @default.
• W3172854200 creator A5045578819 @default.
• W3172854200 creator A5047233718 @default.
• W3172854200 creator A5049302260 @default.
• W3172854200 creator A5052311669 @default.
• W3172854200 creator A5058330133 @default.
• W3172854200 creator A5062670268 @default.
• W3172854200 creator A5084530939 @default.
• W3172854200 creator A5090729869 @default.
• W3172854200 date "2021-06-17" @default.
• W3172854200 modified "2023-10-12" @default.
• W3172854200 title "Asymmetric Synthesis and Biological Screening of Quinoxaline-Containing Synthetic Lipoxin A₄Mimetics (QNX-sLXms)" @default.
• W3172854200 cites W1496642580 @default.
• W3172854200 cites W1531140346 @default.
• W3172854200 cites W1534699340 @default.
• W3172854200 cites W1607772598 @default.
• W3172854200 cites W1638167482 @default.
• W3172854200 cites W1818367061 @default.
• W3172854200 cites W1935740361 @default.
• W3172854200 cites W1963886920 @default.
• W3172854200 cites W1964051296 @default.
• W3172854200 cites W1964147273 @default.
• W3172854200 cites W1964594359 @default.
• W3172854200 cites W1967939624 @default.
• W3172854200 cites W1969874059 @default.
• W3172854200 cites W1970862953 @default.
• W3172854200 cites W1974309015 @default.
• W3172854200 cites W1974975999 @default.
• W3172854200 cites W1980661511 @default.
• W3172854200 cites W1982283061 @default.
• W3172854200 cites W1983795363 @default.
• W3172854200 cites W1986483382 @default.
• W3172854200 cites W1989856248 @default.
• W3172854200 cites W1996076509 @default.
• W3172854200 cites W1996615849 @default.
• W3172854200 cites W2004298032 @default.
• W3172854200 cites W2004334836 @default.
• W3172854200 cites W2014462125 @default.
• W3172854200 cites W2025668501 @default.
• W3172854200 cites W2027596377 @default.
• W3172854200 cites W2032951563 @default.
• W3172854200 cites W2033288172 @default.
• W3172854200 cites W2035641637 @default.
• W3172854200 cites W2037697142 @default.
• W3172854200 cites W2039322235 @default.
• W3172854200 cites W2041831203 @default.
• W3172854200 cites W2043559255 @default.
• W3172854200 cites W2043866217 @default.
• W3172854200 cites W2045251019 @default.
• W3172854200 cites W2045982747 @default.
• W3172854200 cites W2062835892 @default.
• W3172854200 cites W2066041237 @default.
• W3172854200 cites W2076898547 @default.
• W3172854200 cites W2080188146 @default.
• W3172854200 cites W2080459222 @default.
• W3172854200 cites W2086248790 @default.
• W3172854200 cites W2089435101 @default.
• W3172854200 cites W2090609282 @default.
• W3172854200 cites W2091637866 @default.
• W3172854200 cites W2106328365 @default.
• W3172854200 cites W2106792841 @default.
• W3172854200 cites W2116151143 @default.
• W3172854200 cites W2118983744 @default.
• W3172854200 cites W2119492372 @default.
• W3172854200 cites W2123598440 @default.
• W3172854200 cites W2142027687 @default.
• W3172854200 cites W2145217096 @default.
• W3172854200 cites W2146282578 @default.
• W3172854200 cites W2148056149 @default.
• W3172854200 cites W2153454088 @default.
• W3172854200 cites W2170494228 @default.
• W3172854200 cites W2579756956 @default.
• W3172854200 cites W2593091324 @default.
• W3172854200 cites W2610819783 @default.
• W3172854200 cites W2784035341 @default.
• W3172854200 cites W2790342115 @default.
• W3172854200 cites W2790972620 @default.
• W3172854200 cites W2791622411 @default.
• W3172854200 cites W2885534843 @default.
• W3172854200 cites W2889744973 @default.
• W3172854200 cites W2897027772 @default.
• W3172854200 cites W2902615933 @default.
• W3172854200 cites W2905359026 @default.
• W3172854200 cites W2913506254 @default.
• W3172854200 cites W2920818520 @default.
• W3172854200 cites W2950634103 @default.
• W3172854200 cites W2952682879 @default.
• W3172854200 cites W2964952983 @default.

• next